These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
499 related items for PubMed ID: 18287209
1. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction. Ahmet I, Krawczyk M, Zhu W, Woo AY, Morrell C, Poosala S, Xiao RP, Lakatta EG, Talan MI. J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209 [Abstract] [Full Text] [Related]
2. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor. Ahmet I, Morrell C, Lakatta EG, Talan MI. J Pharmacol Exp Ther; 2009 Oct; 331(1):178-85. PubMed ID: 19587314 [Abstract] [Full Text] [Related]
8. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. Badenhorst D, Norton GR, Sliwa K, Brooksbank R, Essop R, Sareli P, Woodiwiss AJ. Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186 [Abstract] [Full Text] [Related]
9. Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Plante E, Lachance D, Gaudreau M, Drolet MC, Roussel E, Arsenault M, Couet J. Circulation; 2004 Sep 14; 110(11):1477-83. PubMed ID: 15353507 [Abstract] [Full Text] [Related]
10. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. Rinaldi B, Donniacuo M, Sodano L, Gritti G, Martuscelli E, Orlandi A, Rafaniello C, Rossi F, Calzetta L, Capuano A, Matera MG. Br J Pharmacol; 2015 Jul 14; 172(14):3627-37. PubMed ID: 25825265 [Abstract] [Full Text] [Related]
14. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure. Omerovic E, Bollano E, Soussi B, Waagstein F. Eur J Heart Fail; 2003 Dec 14; 5(6):725-32. PubMed ID: 14675850 [Abstract] [Full Text] [Related]